ADVANCES IN THE STUDY OF MOLECULAR BASIS OF RESISTANCE TO NEW ANTI-TB DRUGS
- Authors: Peretokina I.V.1, Krylova L.Y.1, Antonova O.V.2, Kholina M.S.2, Gryadunov D.A.2, Nosova E.Y.1, Zimenkov D.V.2
-
Affiliations:
- Moscow Research and Clinical Center for Tuberculosis Control, Moscow
- Engelhardt Institute of Molecular Biology, Russian Academy of Sciences, Moscow
- Issue: Vol 8, No 4 (2018)
- Pages: 577
- Section: TUBERCULOSIS AND MYCOBACTERIA: MOLECULAR APPROACH
- URL: https://ogarev-online.ru/2220-7619/article/view/119227
- DOI: https://doi.org/10.15789/2220-7619-2018-4-6.40
- ID: 119227
Cite item
Full Text
Abstract
About the authors
I. V. Peretokina
Moscow Research and Clinical Center for Tuberculosis Control, Moscow
Author for correspondence.
Russian Federation
L. Yu. Krylova
Moscow Research and Clinical Center for Tuberculosis Control, MoscowRussian Federation
O. V. Antonova
Engelhardt Institute of Molecular Biology, Russian Academy of Sciences, MoscowRussian Federation
M. S. Kholina
Engelhardt Institute of Molecular Biology, Russian Academy of Sciences, MoscowRussian Federation
D. A. Gryadunov
Engelhardt Institute of Molecular Biology, Russian Academy of Sciences, MoscowRussian Federation
E. Yu. Nosova
Moscow Research and Clinical Center for Tuberculosis Control, MoscowRussian Federation
D. V. Zimenkov
Engelhardt Institute of Molecular Biology, Russian Academy of Sciences, MoscowRussian Federation
Supplementary files
